http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-370338-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0ce441f24c8fc6f819196332903963c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59d6e9d04960de7af19164f2f07d6074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd71e451c113da0605c300cdde97c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc345f17e37fe5a23dbfe8b100fda3a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b421d47fac6e3671d11cdbc662305a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251159a8451440cf393823cf378bde2c
publicationDate 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-370338-B
titleOfInvention PHARMACEUTICAL COMPOSITION OF CONDENSED AMINODIHYDROTIAZINE DERIVATIVE.
abstract The present invention provides a pharmaceutical composition comprising a compound represented by the formula (1): (see Formula) or N- [3 - ((4aS, 5R, 7aS) -2-amino-5-methyl-4a, 5, 7,7a-tetrahydro -4H-furo [3,4-d] [1,3] thiazin-7a-yl) -4-fluorophenyl) -5-difluoromethylpyrazine-2-carboxamide, or a pharmaceutically acceptable salt of the foregoing, and a salt of a compound having a C12-22 saturated aliphatic hydrocarbon group.
priorityDate 2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17996518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421005622

Total number of triples: 31.